PS

Paresh Shahaji Chavan

Active Director Director DIN 07518136
DIN 07518136 First appointment Jul 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2016
Shareholding value •••• Premium profile

About Paresh Shahaji Chavan

Data last updated:

Paresh Shahaji Chavan is a Director at Chavan Pharmacy Private Limited (since 2022), Director at Acura Health Solutions Private Limited (since 2016) and Designated Partner at Evaan Residences Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Water Treatment. The 2 current companies with reported revenue have a combined latest revenue of ₹5.13 Cr; the largest is Chavan Pharmacy Private Limited at ₹3.45 Cr (FY 2025). Earlier, Paresh Shahaji Chavan was a Director at Anzit Pharmaceuticals Private Limited (2020–2021).

DIN 07518136
Primary Designation Director
Industry Pharma
First Appointment 09 Jul 2016
Oldest Company Age 10 yrs
Largest company Chavan Pharmacy Private Limited · ₹3.45 Cr (FY 2025)
Combined revenue ₹5.13 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chavan Pharmacy Private Limited U24299PN2022PTC209709
Director26 Mar 20222022₹3.45 Cr (FY 2025)Active
Director09 Jul 20162016₹1.68 Cr (FY 2020)Active
Designated Partner09 Jul 20242024Active
Chavan Lifespaces Private Limited U41000PN2023PTC224871
Director14 Oct 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jan 20202020₹1.23 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evaan Residences Llp
Chavan Pharmacy Private Limited
Acura Health Solutions Private Limited
Chavan Lifespaces Private Limited
Premium access

Shareholding and investment profile for Paresh Shahaji Chavan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Paresh Shahaji Chavan

Paresh Shahaji Chavan currently holds 4 directorships: Chavan Pharmacy Private Limited (Director, since 26 Mar 2022, revenue ₹3.45 Cr (FY 2025)); Acura Health Solutions Private Limited (Director, since 09 Jul 2016, revenue ₹1.68 Cr (FY 2020)); Evaan Residences Llp (Designated Partner, since 09 Jul 2024); Chavan Lifespaces Private Limited (Director, since 14 Oct 2023).

Paresh Shahaji Chavan was first appointed on 09 Jul 2016 as Director at Acura Health Solutions Private Limited. The most recent appointment on record is 09 Jul 2024 at Evaan Residences Llp.

The 2 current companies of Paresh Shahaji Chavan that report revenue have a combined latest revenue of ₹5.13 Cr: Chavan Pharmacy Private Limited ₹3.45 Cr (FY 2025); Acura Health Solutions Private Limited ₹1.68 Cr (FY 2020).

Paresh Shahaji Chavan held 1 earlier board appointment: Anzit Pharmaceuticals Private Limited (Director, 13 Jan 2020 to 27 Oct 2021).

The current boards of Paresh Shahaji Chavan's companies include Shahaji Govindrao Chavan (Chavan Pharmacy Private Limited), Jagruti Paresh Chavan (Acura Health Solutions Private Limited), Marshneil Rishikesh Chavan (Acura Health Solutions Private Limited), Rishikesh Shahaji Chavan (Acura Health Solutions Private Limited), Yogesh Ajit Bafna (Evaan Residences Llp), Aditya Sanjay Gavhane (Chavan Lifespaces Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available